Axsome Therapeutics, Inc. - stock earnings
AXSM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 6, 2024 AfterMarket | - / -1.2020000000 | - | - / 76.9 million | - |
AXSM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -98.7 million USD | 71.5 million USD |
| 2023Q3 | -62.2 million USD | 57.8 million USD |
| 2023Q2 | -67.2 million USD | 46.7 million USD |
| 2023Q1 | -11.2 million USD | 94.6 million USD |
| 2022Q4 | -66.8 million USD | 24.4 million USD |
| 2022Q3 | -47.2 million USD | 16.8 million USD |
| 2022Q2 | -42.8 million USD | 8.8 million USD |
| 2022Q1 | -41.0 million USD | ? USD |
| 2021Q4 | -34.0 million USD | ? USD |
| 2021Q3 | -34.9 million USD | ? USD |
| 2021Q2 | -32.3 million USD | ? USD |
| 2021Q1 | -29.3 million USD | ? USD |
| 2020Q4 | -29.2 million USD | ? USD |
| 2020Q3 | -22.9 million USD | ? USD |
| 2020Q2 | -18.3 million USD | ? USD |
| 2020Q1 | -32.5 million USD | ? USD |
| 2019Q4 | -24.8 million USD | ? USD |
| 2019Q3 | -19.1 million USD | ? USD |
| 2019Q2 | -13.8 million USD | ? USD |
| 2019Q1 | -10.6 million USD | ? USD |
| 2018Q4 | -9.6 million USD | ? USD |
| 2018Q3 | -8.3 million USD | ? USD |
| 2018Q2 | -8.3 million USD | ? USD |
| 2018Q1 | -4.8 million USD | ? USD |
| 2017Q4 | -7.4 million USD | ? USD |
| 2017Q3 | -6.4 million USD | ? USD |
| 2017Q2 | -7.1 million USD | ? USD |
| 2017Q1 | -8.0 million USD | ? USD |
| 2016Q4 | -7.3 million USD | ? USD |
| 2016Q3 | -7.2 million USD | ? USD |
| 2016Q2 | -6.8 million USD | ? USD |
| 2016Q1 | -5.9 million USD | ? USD |
| 2015Q4 | -1.7 million USD | ? USD |
| 2015Q3 | -4.6 million USD | ? USD |
| 2015Q2 | -2.1 million USD | ? USD |
| 2015Q1 | -2.1 million USD | ? USD |
| 2014Q4 | -1.5 million USD | ? USD |
| 2014Q3 | -253118 USD | ? USD |
AXSM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -239.2 million USD | 270.6 million USD |
| 2022 | -197.8 million USD | 50.0 million USD |
| 2021 | -134.9 million USD | 8.8 million USD |
| 2020 | -105.4 million USD | ? USD |
| 2019 | -69.7 million USD | ? USD |
| 2018 | -31.0 million USD | ? USD |
| 2017 | -28.9 million USD | ? USD |
| 2016 | -27.2 million USD | ? USD |
| 2015 | -10.6 million USD | ? USD |
| 2014 | -6.0 million USD | ? USD |
| 2013 | -2.2 million USD | ? USD |
AXSM
Price: $74.80
52 week price:
Earnings Per Share: -5.27 USD
P/E Ratio: -20.31
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.9 million
Ebitda: -6.3 millionMarket Capitalization: 3.4 billion